Michelle Staudt to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Michelle Staudt has written about Xenograft Model Antitumor Assays.
Connection Strength
0.234
-
The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res. 2004 Jul 15; 64(14):4790-9.
Score: 0.218
-
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood. 2007 Mar 01; 109(5):2165-73.
Score: 0.016